Indicators

Markets:

News

Latest News about alcohol use disorder

Recent news which mentions alcohol use disorder

Could Psychedelics End Binge Drinking? A Breakthrough Patent Says Yes

August 23, 2024

Can CBD Help With Alcohol Use Disorder? New Scientific Review Finds There's Something To It

March 22, 2024

Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors

March 12, 2024

Awakn Life Sciences Submits CTA For Phase III Alcohol Use Disorder Clinical Trial

September 06, 2023

Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials

August 23, 2023

Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next

July 05, 2023

Biden's Younger Bro: President Is 'Very Open-Minded' On Benefits Of Psychedelics

June 29, 2023

FSD Pharma Announces Agreement To Grant Exclusive Rights To Recreational Alcohol Misuse Technology

June 20, 2023

Awakn To Focus On R&D Of Addiction Therapies, Moves Away From Ketamine Treatment For Alcoholism

June 12, 2023

Psilocybin Therapy: Potential For Treating Alcoholism Examined In APA Publication

June 05, 2023

MEAI Compound's First Clinical Trial In US, Clearmind Enters NASDAQ Compliance Period

May 22, 2023

EXCLUSIVE: Clearmind Medicine Secures Approval To Launch Clinical Trial For Alcohol Addiction Treatment

May 12, 2023

Next-Gen Israeli Psychedelics Company Gears Up For Trial Targeting Alcohol Addiction

May 03, 2023

Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion

April 28, 2023

UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage

April 05, 2023

A Drug That Mimics Alcohol Buzz Is Bound For Human Trials: Here's What's Next

March 17, 2023

Shark Tank's Kevin Harrington Will Provide Strategic Guidance To Major Psychedelics Company

February 28, 2023

Awakn's First Licensing Partnership Deal In Europe Involves Chain Of Portuguese Clinics

February 22, 2023

Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program

February 14, 2023

Clinical Site In Alberta Begins Study Of Psychedelic-Assisted Treatment For Alcohol Use Disorder

February 07, 2023

Awakn's Ketamine Treatment For Alcohol Use Disorder Awarded UK's Fast-Track Status

February 07, 2023

Recreational Cannabis Legalization Correlated With Decrease In Alcohol Use Disorder, New Study Finds

January 30, 2023

EXCLUSIVE: Next-Generation Psychedelics, MEAI - What And When

January 24, 2023

Psychiatry And Business Collaborate: European Psychedelics Trial Tackles Alcohol Addiction

January 20, 2023

What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways

January 03, 2023

47% of Adults With Alcohol Use Disorder Sought Help Because of Family Encouragement

December 08, 2022

Europe To Have Expanded Access To Psychedelic-Assisted Therapy With New Norway Clinic

December 03, 2022

Clearmind Gears Up For Clinical Trial To Test Drug That Treats Alcohol Addiction

November 23, 2022

A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here's The Latest

November 23, 2022

EXCLUSIVE: New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC

November 09, 2022

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.